RNA interference (RNAi) technology has emerged as one of the most promising innovations in molecular biology and biotechnology, with high potential in therapeutic, agricultural, and research ...

Green calls this approach of fine-tuning specific cells' activity "genetic surgery ... 19 vaccines are the best known ...

The United States Tumor Profiling Market is projected to surge from US$ 3.41 billion in 2024 to US$ 7.44 billion by 2033, ...

Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...

Eight breakthrough technologies that are redefining how we discover drugs, deliver care, and create a more connected and ...

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

Receiving a platform technology designation from the FDA is a tremendous milestone for our development team and Krystal, both as recognition of the reproducibility and scalability of our HSV-1 gene ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

October marks Global Breast Cancer Awareness Month with several ASX companies working to advance early detection and ...

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...